We are live on
!
Find out more
GP
Girard Partners Portfolio holdings
AUM
$1.06B
1-Year Est. Return
17.26%
This Fund
S&P 500
This Quarter
Est. Return
-10.62%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$476M
AUM Growth
-$87.9M
(-16%)
Cap. Flow
-$24.5M
Cap. Flow
% of AUM
-5.15%
Top 10 Holdings %
Top 10 Hldgs %
24.41%
Holding
980
New
1
Increased
109
Reduced
113
Closed
737
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
|
+$2.96M |
| 2 |
iShares MSCI EAFE Growth ETF
EFG
|
+$2.31M |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$2.27M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$2.1M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$1.86M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.35M |
| 3 |
ExxonMobil
XOM
|
+$1.26M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
+$1.12M |
| 5 |
Vanguard Large-Cap ETF
VV
|
+$1.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.61% |
| 2 | Financials | 12.48% |
| 3 | Technology | 12.41% |
| 4 | Industrials | 8.66% |
| 5 | Consumer Discretionary | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
CME Group
CME
$92.1B
| $695K | 0.15% |
3,694
-61
| -2% | -$11.3K |
|
127
Invesco QQQ Trust
QQQ
$449B
| $690K | 0.15% |
4,475
+523
| +13% | +$87.5K |
|
|
CELG
128
DELISTED
Celgene Corp
CELG
| $681K | 0.14% |
10,631
-5,124
| -33% | -$378K |
|
129
iShares US Technology ETF
IYW
$23.4B
| $677K | 0.14% |
16,952
+13,200
| +352% | +$572K |
|
130
Global Payments
GPN
$22.9B
| $655K | 0.14% |
6,359
+885
| +16% | +$97.5K |
|
|
131
Vanguard Large-Cap ETF
VV
$51.9B
| $651K | 0.14% |
5,672
-8,972
| -61% | -$1.11M |
|
132
Vanguard Small-Cap ETF
VB
$79.9B
| $621K | 0.13% |
4,704
-725
| -13% | -$106K |
|
133
Aflac
AFL
$64.4B
| $617K | 0.13% |
13,552
-36
| -0.3% | -$1.6K |
|
134
PNC Financial Services
PNC
$99.5B
| $615K | 0.13% |
5,264
+1,321
| +34% | +$169K |
|
135
Mondelez International
MDLZ
$77.9B
| $613K | 0.13% |
15,314
-1
| -0% | -$43 |
|
136
Berkshire Hathaway Class A
BRK.A
$1.07T
| $612K | 0.13% |
2
| – | – |
|
|
ATVI
137
DELISTED
Activision Blizzard
ATVI
| $611K | 0.13% |
13,126
-926
| -7% | -$55.4K |
|
138
iShares MSCI EAFE ETF
EFA
$76.8B
| $608K | 0.13% |
10,352
+6,384
| +161% | +$399K |
|
|
BNY
139
Bank of New York Mellon
BNY
$107B
| $606K | 0.13% |
12,880
+10,520
| +446% | +$511K |
|
140
iShares US Healthcare ETF
IYH
$3.39B
| $586K | 0.12% |
16,225
+4,975
| +44% | +$191K |
|
141
M&T Bank
MTB
$35.9B
| $574K | 0.12% |
4,011
-14
| -0.3% | -$2.24K |
|
142
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $573K | 0.12% |
7,052
-10,829
| -61% | -$867K |
|
143
Gilead Sciences
GILD
$163B
| $572K | 0.12% |
9,155
-5,004
| -35% | -$350K |
|
144
Duke Energy
DUK
$101B
| $570K | 0.12% |
6,612
+220
| +3% | +$18.7K |
|
145
Sysco
SYY
$40.2B
| $568K | 0.12% |
9,080
+4,360
| +92% | +$294K |
|
146
Netflix
NFLX
$294B
| $564K | 0.12% |
21,080
-780
| -4% | -$23.3K |
|
|
147
Vanguard Mid-Cap ETF
VO
$106B
| $550K | 0.12% |
15,928
-29,748
| -65% | -$1.12M |
|
148
FedEx
FDX
$73.2B
| $545K | 0.11% |
3,382
+523
| +18% | +$111K |
|
|
149
Vanguard S&P 500 ETF
VOO
$969B
| $530K | 0.11% |
2,308
-5,450
| -70% | -$1.35M |
|
150
Eli Lilly
LLY
$1.07T
| $517K | 0.11% |
4,471
-862
| -16% | -$96.3K |
|
Similar funds
PO
PRIG
KI
H
RVPG
AC
AT
IFAM
Girard Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Girard Partners held 980 positions worth $476M, down 16% from $564M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Girard Partners withdrew a net $24.5M in Q4 2018, closing 737 positions and reducing 113 holdings. Its most notable exit was Praxair Inc, an estimated $1.86M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, Girard Partners opened a new position in Linde worth $1.37M.
- Girard Partners's largest Q4 2018 buy was Linde: 8,798 shares worth $1.37M.
- Girard Partners added most to State Street SPDR Portfolio Aggregate Bond ETF in Q4 2018, an estimated $2.96M increase.
- Girard Partners's biggest Q4 2018 reduction was Vanguard S&P 500 ETF, cutting an estimated $1.35M.
- Girard Partners fully exited Praxair Inc in Q4 2018, selling an estimated $1.86M.
- Girard Partners's ten largest holdings make up 24% of its $476M portfolio in Q4 2018.
- Girard Partners opened 1 new position and closed 737 in Q4 2018.
- Girard Partners's portfolio value fell 16% quarter-over-quarter to $476M.
Based on Girard Partners's 13F filing for Q4 2018, filed 11 Feb 2019.